Genedant

Genedant is a venture capital firm established in 2020 and based in Singapore. It specializes in early-stage investments, targeting pre-seed to Series A funding rounds within the deep tech sector, particularly in the fields of pharmaceuticals, agrifood, and computing or quantum sciences. The firm aims to challenge traditional paradigms in life sciences and technology by supporting innovative companies with a global outlook, especially those with potential for expansion in Asia. Genedant focuses on emerging opportunities that align with its commitment to advancing deep science and transformative technologies.

Yiren Chen

Managing Director

2 past transactions

UMAMI Bioworks

Seed Round in 2022
Umami Meats develops cultured seafood based on a proprietary, low-cost, and sustainable formulation of growth factors.

Sequential Skin

Seed Round in 2021
Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.